A phase II study of Irinotecan (CPT-11) for Leiomyosarcoma of Uterus.
Phase of Trial: Phase II
Latest Information Update: 13 Jan 2010
At a glance
- Drugs Irinotecan (Primary)
- Indications Uterine leiomyoma
- Focus Therapeutic Use
- 13 Jan 2010 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 08 Jun 2009 New trial record.